125 related articles for article (PubMed ID: 24957690)
1. Baccatin III, a precursor for the semisynthesis of paclitaxel, inhibits the accumulation and suppressive activity of myeloid-derived suppressor cells in tumor-bearing mice.
Lee YH; Lee YR; Park CS; Im SA; Song S; Hong JT; Whang BY; Kim K; Lee CK
Int Immunopharmacol; 2014 Aug; 21(2):487-93. PubMed ID: 24957690
[TBL] [Abstract][Full Text] [Related]
2. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.
Lee YH; Lee YR; Kim KH; Im SA; Song S; Lee MK; Kim Y; Hong JT; Kim K; Lee CK
Int Immunopharmacol; 2011 Aug; 11(8):985-91. PubMed ID: 21354357
[TBL] [Abstract][Full Text] [Related]
3. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
4. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
Sinha P; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
[TBL] [Abstract][Full Text] [Related]
6. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
7. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
[TBL] [Abstract][Full Text] [Related]
8. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
[TBL] [Abstract][Full Text] [Related]
9. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
[TBL] [Abstract][Full Text] [Related]
10. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
[TBL] [Abstract][Full Text] [Related]
11. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
[TBL] [Abstract][Full Text] [Related]
12. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.
Kodumudi KN; Woan K; Gilvary DL; Sahakian E; Wei S; Djeu JY
Clin Cancer Res; 2010 Sep; 16(18):4583-94. PubMed ID: 20702612
[TBL] [Abstract][Full Text] [Related]
13. Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells.
Lee M; Park CS; Lee YR; Im SA; Song S; Lee CK
Arch Pharm Res; 2014; 37(9):1234-40. PubMed ID: 24748512
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.
Fernández A; Mesa C; Marigo I; Dolcetti L; Clavell M; Oliver L; Fernández LE; Bronte V
J Immunol; 2011 Jan; 186(1):264-74. PubMed ID: 21135171
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
[TBL] [Abstract][Full Text] [Related]
16. Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
Manrique SZ; Dominguez AL; Mirza N; Spencer CD; Bradley JM; Finke JH; Lee JJ; Pease LR; Gendler SJ; Cohen PA
Oncotarget; 2016 Jul; 7(28):42919-42942. PubMed ID: 27341020
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2'-methyl taxoids derived from baccatin III and 14beta-OH-baccatin III 1,14-carbonate.
Battaglia A; Bernacki RJ; Bertucci C; Bombardelli E; Cimitan S; Ferlini C; Fontana G; Guerrini A; Riva A
J Med Chem; 2003 Nov; 46(23):4822-5. PubMed ID: 14584931
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE
Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184
[TBL] [Abstract][Full Text] [Related]
20. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL
Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
